Search

This study explores how patient-centredness is understood and applied in research and innovation (R&I) across the European Union. Drawing on case studies from Germany, the Netherlands, and Belgium, and insights from a range of stakeholders, it aims to inform future policy and practice. While patient-centredness is gaining prominence at the EU level, its implementation remains variable across Member States and funding instruments. Overall, the findings highlight both the recognised value of patient ...

This briefing provides a summary overview on the public health system and pharmaceutical industry in Poland. Poland combines a comparatively large pharmaceutical market with a health system that remains relatively underfunded by EU standards. Poland has a meaningful domestic manufacturing base, especially in generics and over the counter (OTC) products, but it is still highly dependent on imported active pharmaceutical ingredients (APIs) and many finished medicines. This makes “critical medicines ...

Newborn screening is an established preventive healthcare practice that enables the detection and treatment of health conditions at an early stage. It could reduce the risk of 'diagnostic odyssey' often experienced by persons affected by rare diseases, which in Europe are defined as health conditions that affect less than 1 in 2 000 persons. This briefing presents the findings of a desk review of publicly available sources on newborn screening practices in the EU and the United States (US), which ...

The infographic “Menopause Care in the EU” supports the joint SANT/FEMM public hearing on menopause by presenting key information on menopause, its symptoms, and potential treatments, and by highlighting the results of the European Parliament’s consultation on women’s health regarding the state of menopause care in the EU.

On 16 December 2025, the European Commission put forward a proposal for a regulation to simplify the rules governing medical devices in the EU. The proposal forms part of a broader package of measures aimed at improving citizens' health and strengthening the resilience and competitiveness of the health sector. An evaluation of the current EU regulatory framework for medical devices concluded that it has led to unnecessary costs, administrative bottlenecks, regulatory uncertainty for companies, and ...

This study assesses how the proposed National and Regional Partnership Plans (NRPPs) Regulation restructures the support relevant to Cohesion Policy and regional development. Based on this analysis, it formulates policy recommendations on how the Proposal could be adjusted to better achieve cohesion objectives. This document was commissioned by the European Parliament’s Policy Department for Regional Development, Agriculture and Fisheries at the request of the Regional Development Committee.